NCT02611024 2025-07-09Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid TumorsPharmaMarPhase 1/2 Completed316 enrolled
NCT04902872 2025-01-23Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid TumorsCybrexa TherapeuticsPhase 1/2 Active not recruiting130 enrolled
NCT05199272 2024-11-15A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies23andMe, Inc.Phase 1/2 Active not recruiting141 enrolled
NCT05620134 2024-10-15Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic CancerSalubris Biotherapeutics IncPhase 1/2 Active not recruiting263 enrolled
NCT03330405 2023-10-13Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid TumorsPfizerPhase 1/2 Terminated223 enrolled 50 charts
NCT01631552 2021-08-12Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial CancerGilead SciencesPhase 1/2 Completed515 enrolled 28 charts 2 FDA
NCT00003103 2013-07-03Chemotherapy in Treating Patients With Solid TumorsMemorial Sloan Kettering Cancer CenterPhase 1/2 Completed57 enrolled
NCT00063895 2013-01-09Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and NeckNational Cancer Institute (NCI)Phase 1/2 Completed80 enrolled